Commentary: "Baicalein mediates the anti-tumor activity in Osteosarcoma through lncRNA-NEF driven Wnt/β-catenin signaling regulatory axis".
作者信息
Wang Xinluan
机构信息
Translational Medicine R&D Center, Institute of Biomedical and Health Engineering, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, 518055, China.
出版信息
J Orthop Translat. 2022 Oct 28;35:A3. doi: 10.1016/j.jot.2022.10.011. eCollection 2022 Jul.
Abstract
摘要
相似文献
1
Commentary: "Baicalein mediates the anti-tumor activity in Osteosarcoma through lncRNA-NEF driven Wnt/β-catenin signaling regulatory axis".评论：“黄芩素通过lncRNA-NEF驱动的Wnt/β-连环蛋白信号调节轴介导骨肉瘤的抗肿瘤活性”。
J Orthop Translat. 2022 Oct 28;35:A3. doi: 10.1016/j.jot.2022.10.011. eCollection 2022 Jul.
2
Baicalein mediates the anti-tumor activity in Osteosarcoma through lncRNA-NEF driven Wnt/β-catenin signaling regulatory axis.黄芩素通过lncRNA-NEF驱动的Wnt/β-连环蛋白信号调节轴介导骨肉瘤的抗肿瘤活性。
J Orthop Translat. 2022 Mar 11;33:132-141. doi: 10.1016/j.jot.2021.12.001. eCollection 2022 Mar.
3
Baicalein inhibits progression of osteosarcoma cells through inactivation of the Wnt/β-catenin signaling pathway.黄芩素通过使Wnt/β-连环蛋白信号通路失活来抑制骨肉瘤细胞的进展。
Oncotarget. 2017 Sep 18;8(49):86098-86116. doi: 10.18632/oncotarget.20987. eCollection 2017 Oct 17.
4
Baicalein suppresses the viability of MG-63 osteosarcoma cells through inhibiting c-MYC expression via Wnt signaling pathway.黄芩素通过Wnt信号通路抑制c-MYC表达，从而抑制MG-63骨肉瘤细胞的活力。
Mol Cell Biochem. 2015 Jul;405(1-2):187-96. doi: 10.1007/s11010-015-2410-6. Epub 2015 Apr 18.
5
LncRNA-NEF antagonized epithelial to mesenchymal transition and cancer metastasis via cis-regulating FOXA2 and inactivating Wnt/β-catenin signaling.长链非编码 RNA-NEF 通过顺式调控 FOXA2 和失活 Wnt/β-catenin 信号来拮抗上皮间质转化和癌症转移。
Oncogene. 2018 Mar;37(11):1445-1456. doi: 10.1038/s41388-017-0041-y. Epub 2018 Jan 9.
6
Long non-coding RNA MINCR regulates the growth and metastasis of human osteosarcoma cells via Wnt/β-catenin signaling pathway.长链非编码 RNA MINCR 通过 Wnt/β-catenin 信号通路调节人骨肉瘤细胞的生长和转移。
Acta Biochim Pol. 2022 Jun 29;69(3):551-557. doi: 10.18388/abp.2020_5804.
7
LncRNA-NEF inhibits proliferation, migration and invasion of esophageal squamous-cell carcinoma cells by inactivating wnt/β-catenin pathway.长链非编码 RNA-NEF 通过抑制 wnt/β-连环蛋白通路抑制食管鳞状细胞癌细胞的增殖、迁移和侵袭。
Eur Rev Med Pharmacol Sci. 2018 Oct;22(20):6824-6831. doi: 10.26355/eurrev_201810_16150.
8
Long non-coding RNA (LncRNA) MRPL23-AS1 promotes tumor progression and carcinogenesis in osteosarcoma by activating Wnt/β-catenin signaling via inhibiting microRNA miR-30b and upregulating myosin heavy chain 9 (MYH9).长链非编码 RNA（LncRNA）MRPL23-AS1 通过抑制 microRNA miR-30b 和上调肌球蛋白重链 9（MYH9）来激活 Wnt/β-catenin 信号通路，从而促进骨肉瘤的肿瘤进展和致癌作用。
Bioengineered. 2021 Dec;12(1):162-171. doi: 10.1080/21655979.2020.1863014.
9
Long non-coding RNA NEF inhibits proliferation and promotes apoptosis of laryngeal squamous cell carcinoma cells by inhibiting Wnt/β-catenin signaling.长链非编码RNA NEF通过抑制Wnt/β-连环蛋白信号通路抑制喉鳞状细胞癌细胞的增殖并促进其凋亡。
Oncol Lett. 2019 Jun;17(6):4928-4934. doi: 10.3892/ol.2019.10150. Epub 2019 Mar 15.
10
LncRNA BE503655 inhibits osteosarcoma cell proliferation, invasion/migration via Wnt/β-catenin pathway.长链非编码 RNA BE503655 通过 Wnt/β-连环蛋白通路抑制骨肉瘤细胞的增殖、侵袭/迁移。
Biosci Rep. 2019 Jul 29;39(7). doi: 10.1042/BSR20182200. Print 2019 Jul 31.
本文引用的文献
1
Baicalein mediates the anti-tumor activity in Osteosarcoma through lncRNA-NEF driven Wnt/β-catenin signaling regulatory axis.黄芩素通过lncRNA-NEF驱动的Wnt/β-连环蛋白信号调节轴介导骨肉瘤的抗肿瘤活性。
J Orthop Translat. 2022 Mar 11;33:132-141. doi: 10.1016/j.jot.2021.12.001. eCollection 2022 Mar.
2
Potential of natural products in osteosarcoma treatment: Focus on molecular mechanisms.天然产物在骨肉瘤治疗中的潜力：聚焦分子机制。
Biomed Pharmacother. 2021 Dec;144:112257. doi: 10.1016/j.biopha.2021.112257. Epub 2021 Oct 20.
3
Apatinib ameliorates doxorubicin-induced migration and cancer stemness of osteosarcoma cells by inhibiting Sox2 via STAT3 signalling.阿帕替尼通过STAT3信号通路抑制Sox2，改善阿霉素诱导的骨肉瘤细胞迁移和癌症干性。
J Orthop Translat. 2019 Aug 7;22:132-141. doi: 10.1016/j.jot.2019.07.003. eCollection 2020 May.
4
Chinese herbal Huo-Gu formula for the treatment of steroid-associated osteonecrosis of femoral head: A 14-year follow-up of convalescent SARS patients.治疗类固醇相关股骨头坏死的中药活骨方：对康复期非典患者的14年随访
J Orthop Translat. 2020 Apr 4;23:122-131. doi: 10.1016/j.jot.2020.03.014. eCollection 2020 Jul.
5
Poly(ethylene glycol)-sheddable reduction-sensitive polyurethane micelles for triggered intracellular drug delivery for osteosarcoma treatment.用于骨肉瘤治疗的触发式细胞内药物递送的聚乙二醇可脱落还原敏感型聚氨酯胶束
J Orthop Translat. 2019 Dec 6;21:57-65. doi: 10.1016/j.jot.2019.11.001. eCollection 2020 Mar.
6
Huo Xue Tong Luo capsule, a vasoactive herbal formula prevents progression of asymptomatic osteonecrosis of femoral head: A prospective study.活血通络胶囊，一种血管活性草药配方，可预防无症状性股骨头坏死的进展：一项前瞻性研究。
J Orthop Translat. 2018 Dec 21;18:65-73. doi: 10.1016/j.jot.2018.11.002. eCollection 2019 Jul.
7
Herbal Fufang Xian Ling Gu Bao prevents corticosteroid-induced osteonecrosis of the femoral head-A first multicentre, randomised, double-blind, placebo-controlled clinical trial.中药复方仙灵骨葆预防糖皮质激素性股骨头坏死——一项首次多中心、随机、双盲、安慰剂对照临床试验
J Orthop Translat. 2017 Dec 14;12:36-44. doi: 10.1016/j.jot.2017.11.001. eCollection 2018 Jan.
8
Natural compounds targeting major cell signaling pathways: a novel paradigm for osteosarcoma therapy.靶向主要细胞信号通路的天然化合物：骨肉瘤治疗的新范例
J Hematol Oncol. 2017 Jan 7;10(1):10. doi: 10.1186/s13045-016-0373-z.
9
The first multicenter and randomized clinical trial of herbal Fufang for treatment of postmenopausal osteoporosis.中药复方治疗绝经后骨质疏松症的首个多中心随机临床试验。
Osteoporos Int. 2012 Apr;23(4):1317-27. doi: 10.1007/s00198-011-1577-2. Epub 2011 Apr 20.
Zotero 插件